Artisan Partners
ALXN

Artisan Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Artisan Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,066,254
Closed -$95.7M – 342
2020
Q1 		$95.7M Sell
1,066,254
-2,235,445
-68% -$219M 0.21% 110
2019
Q4 		$357M Sell
3,301,699
-1,550,736
-32% -$166M 0.63% 51
2019
Q3 		$475M Sell
4,852,435
-174,629
-3% -$19.7M 0.9% 38
2019
Q2 		$658M Buy
5,027,064
+778,816
+18% +$100M 1.21% 25
2019
Q1 		$574M Buy
4,248,248
+2,924,550
+221% +$364M 1.13% 29
2018
Q4 		$129M Sell
1,323,698
-67,635
-5% -$7.99M 0.29% 78
2018
Q3 		$193M Buy
1,391,333
+293,689
+27% +$36.8M 0.37% 79
2018
Q2 		$136M Buy
1,097,644
+49,488
+5% +$5.78M 0.27% 99
2018
Q1 		$117M Buy
1,048,156
+453,196
+76% +$54.2M 0.24% 113
2017
Q4 		$71.2M Buy
+594,960
New +$72.5M 0.13% 155
2015
Q1 		– Sell
-537,495
Closed -$99.5M – 389
2014
Q4 		$99.5M Sell
537,495
-946,959
-64% -$175M 0.17% 147
2014
Q3 		$246M Sell
1,484,454
-327,910
-18% -$53.9M 0.44% 75
2014
Q2 		$283M Sell
1,812,364
-504,089
-22% -$79.6M 0.49% 63
2014
Q1 		$352M Buy
2,316,453
+14,820
+0.6% +$2.36M 0.62% 48
2013
Q4 		$306M Sell
2,301,633
-15,244
-0.7% -$1.83M 0.55% 60
2013
Q3 		$269M Buy
2,316,877
+256,077
+12% +$28.1M 0.52% 65
2013
Q2 		$190M Buy
+2,060,800
New +$199M 0.41% 95

Other funds holding ALXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners's ALXN Position: Q2 2020 in Review

Artisan Partners sold out of Alexion Pharmaceuticals (ALXN) in Q2 2020, closing a stake of 1,066,254 shares — an estimated $95.7M sold.

Artisan Partners first reported a position in ALXN in Q2 2013 and held it in 17 quarters. The position peaked at $658M in Q2 2019. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2020.

  • Artisan Partners reported no remaining Alexion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Artisan Partners sold 1,066,254 Alexion Pharmaceuticals shares in Q2 2020, an estimated $95.7M.
  • Artisan Partners first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Artisan Partners's Alexion Pharmaceuticals position peaked at $658M in Q2 2019.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2020.

Based on Artisan Partners's 13F filing for Q2 2020, filed 12 Aug 2020.